Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 1, Pages 16
Publisher
MDPI AG
Online
2019-12-23
DOI
10.3390/cancers12010016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
- (2019) Börje Ljungberg et al. EUROPEAN UROLOGY
- The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications
- (2019) W. Marston Linehan et al. Nature Reviews Urology
- Systematic Analysis of Drug Vulnerabilities Conferred by Tumor Suppressor Loss
- (2019) Hongyu Ding et al. Cell Reports
- Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma
- (2019) David A. Braun et al. JAMA Oncology
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
- (2018) Samra Turajlic et al. CELL
- Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma
- (2018) Zhun Wang et al. CLINICA CHIMICA ACTA
- Relationship of tumor mutational burden (TMB) to immunotherapy response in metastatic renal cell carcinoma (mRCC).
- (2018) Manuel C. Maia et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- (2018) David F. McDermott et al. NATURE MEDICINE
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
- (2018) Diana Miao et al. SCIENCE
- The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
- (2018) Christopher J. Ricketts et al. Cell Reports
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostication in Kidney Cancer: Recent Advances and Future Directions
- (2018) Jeffrey Graham et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study
- (2018) Martin H Voss et al. LANCET ONCOLOGY
- Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
- (2017) James J. Hsieh et al. EUROPEAN UROLOGY
- Systemic Therapy for Metastatic Renal-Cell Carcinoma
- (2017) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
- (2017) Daniel M. Tennenbaum et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade
- (2017) Yi-Feng Gu et al. Cancer Discovery
- Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma
- (2017) Wei Jiang et al. Oncotarget
- Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma
- (2017) A Murakami et al. Oncogenesis
- The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry
- (2017) Sung Han Kim et al. PLoS One
- Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
- (2016) D. J. Kwiatkowski et al. CLINICAL CANCER RESEARCH
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma
- (2016) Andre P. Fay et al. Journal of the National Comprehensive Cancer Network
- Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression
- (2016) Richard W. Joseph et al. JOURNAL OF UROLOGY
- PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma
- (2016) Basudev Chowdhury et al. PLoS One
- SWI/SNF Chromatin Remodeling and Human Malignancies
- (2015) Julien Masliah-Planchon et al. Annual Review of Pathology-Mechanisms of Disease
- TP53: an oncogene in disguise
- (2015) T Soussi et al. CELL DEATH AND DIFFERENTIATION
- A germline mutation inPBRM1predisposes to renal cell carcinoma
- (2015) Patrick R Benusiglio et al. JOURNAL OF MEDICAL GENETICS
- PBRM1 (BAF180) protein is functionally regulated by p53-induced protein degradation in renal cell carcinomas
- (2015) Stephan Macher-Goeppinger et al. JOURNAL OF PATHOLOGY
- The Impact of PBRM1 Expression as a Prognostic and Predictive Marker in Metastatic Renal Cell Carcinoma
- (2015) Ji-Yeon Kim et al. JOURNAL OF UROLOGY
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma
- (2015) Soo Jeong Nam et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy
- (2014) M. H. Voss et al. CLINICAL CANCER RESEARCH
- Molecular Genetics of Clear-Cell Renal Cell Carcinoma
- (2014) James Brugarolas JOURNAL OF CLINICAL ONCOLOGY
- Requirement for PBAF in Transcriptional Repression and Repair at DNA Breaks in Actively Transcribed Regions of Chromatin
- (2014) Andreas Kakarougkas et al. MOLECULAR CELL
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- BAF180 Promotes Cohesion and Prevents Genome Instability and Aneuploidy
- (2014) Peter M. Brownlee et al. Cell Reports
- Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma
- (2013) Walter H. da Costa et al. BJU INTERNATIONAL
- Cooperation and Antagonism among Cancer Genes: The Renal Cancer Paradigm
- (2013) S. Pena-Llopis et al. CANCER RESEARCH
- Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
- (2013) A. A. Hakimi et al. CLINICAL CANCER RESEARCH
- Clinical and pathological impact ofVHL, PBRM1, BAP1, SETD2, KDM6A, andJARID1cin clear cell renal cell carcinoma
- (2013) Lucy Gossage et al. GENES CHROMOSOMES & CANCER
- Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation
- (2013) Payal Kapur et al. LANCET ONCOLOGY
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- A Review of Integrated Staging Systems for Renal Cell Carcinoma
- (2012) Malek Meskawi et al. EUROPEAN UROLOGY
- Loss of PBRM1 expression is associated with renal cell carcinoma progression
- (2012) Rafal Pawłowski et al. INTERNATIONAL JOURNAL OF CANCER
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- ATP-dependent chromatin remodeling: genetics, genomics and mechanisms
- (2011) Diana C Hargreaves et al. CELL RESEARCH
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- The genetic basis of kidney cancer: a metabolic disease
- (2010) W. Marston Linehan et al. Nature Reviews Urology
- Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence
- (2010) A. E. Burrows et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer
- (2008) W. Xia et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started